CoChat
Sign Up
Cited by 0

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Bioorthogonal click chemistry to visualize an immunogenic HLA-A2-restricted hepatitis B virus epitope in human monocyte-derived dendritic cells

Mostert, Thijmen P, Kessler, Amy L, Luijten, Robbie J, Doelman, Ward, Isendoorn, Marjolein M E, Filippov, Dmitri V, van Kasteren, Sander I, Buschow, Sonja I·2026·The Journal of Immunology
DOI 10.1093/jimmun/vkaf312
Open this paper in CoChat — free account

Abstract

Peptide-based therapeutic vaccines exploit cross-presentation by dendritic cells for the induction of effective T cell responses. Their clinical success, however, has been limited due to incomplete understanding of antigen processing and presentation (APP). Bioorthogonal chemistry (BOC) uses chemical “click” reactions that can be performed selectively without interference of the cellular environment. A “click handle” can be incorporated into a biomolecule with only minor effects on its characteristics, allowing selective visualization and tracking of the biomolecule. We generated 10 analogues of the HLA-A2-restricted, immunogenic hepatitis B virus-derived epitope HBcAg18-27 by replacing each amino acid with the click handle homopropargylglycine. Each analogue was tested for (1) peptide binding affinity to HLA-A2, (2) preservation of immunogenicity, and (3) accessibility for on-cell click reactions. Lastly, we performed a proof-of-concept experiment in which we demonstrate the feasibility of BOC for APP studies. All amino acids could be modified with the click handle without loss of HLA binding. Furthermore, 7 out of 10 analogues retained cognate T cell recognition. Two of the most promising analogues were tested and demonstrated to be accessible for on-cell click as well as suitable for long peptide processing and presentation studies. To our knowledge, we are the first to show the feasibility of BOC to study APP in the human setting. With BOC techniques, we may now be able to sensitively follow antigen routing by visualizing the intracellular location of (long) peptides. Furthermore, this tool enables direct and quantitative epitope studies in a T cell-independent manner.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/jimmun/vkaf312

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 75

  1. Neefjes, 2011, Towards a systems understanding of MHC class I and MHC class II antigen presentation, Nat Rev Immunol, 11, 823, 10.1038/nri3084 · DOI · Paper page
  2. Pishesha, 2022, A guide to antigen processing and presentation, Nat Rev Immunol, 22, 751, 10.1038/s41577-022-00707-2 · DOI · Paper page
  3. Rock, 2016, Present yourself! By MHC Class I and MHC Class II molecules, Trends Immunol, 37, 724, 10.1016/j.it.2016.08.010 · DOI · Paper page
  4. Hwang, 2020, Recent insights of T cell receptor-mediated signaling pathways for T cell activation and development, Exp Mol Med, 52, 750, 10.1038/s12276-020-0435-8 · DOI
  5. Pollard, 2021, A guide to vaccinology: from basic principles to new developments, Nat Rev Immunol, 21, 83, 10.1038/s41577-020-00479-7 · DOI · Paper page
  6. Tian, 2022, Development of therapeutic vaccines for the treatment of diseases, Mol Biomed, 3, 40, 10.1186/s43556-022-00098-9 · DOI
  7. Kenison, 2024, Therapeutic induction of antigen-specific immune tolerance, Nat Rev Immunol, 24, 338, 10.1038/s41577-023-00970-x · DOI
  8. Cruz, 2023, Pathways of MHC I cross-presentation of exogenous antigens, Semin Immunol, 66, 101729, 10.1016/j.smim.2023.101729 · DOI
  9. Embgenbroich, 2018, Current concepts of antigen cross-presentation, Front Immunol, 9, 1643, 10.3389/fimmu.2018.01643 · DOI
  10. Nair-Gupta, 2014, TLR signals induce phagosomal MHC-I delivery from the endosomal recycling compartment to allow cross-presentation, Cell, 158, 506, 10.1016/j.cell.2014.04.054 · DOI
  11. Blander, 2006, Toll-dependent selection of microbial antigens for presentation by dendritic cells, Nature, 440, 808, 10.1038/nature04596 · DOI
  12. Boross, 2014, FcRγ-Chain ITAM signaling is critically required for cross-presentation of soluble antibody-antigen complexes by dendritic cells, J Immunol, 193, 5506, 10.4049/jimmunol.1302012 · DOI
  13. Dahan, 2012, T-cell-receptor-like antibodies—generation, function and applications, Expert Rev Mol Med, 14, e6, 10.1017/erm.2012.2 · DOI
  14. Li, 2022, TCR-like antibodies targeting autoantigen-mhc complexes: a mini-review, Front Immunol, 13, 968432, 10.3389/fimmu.2022.968432 · DOI
  15. Norbury, 1997, Constitutive macropinocytosis allows TAP-dependent major histocompatibility complex class I presentation of exogenous soluble antigen by bone marrow-derived dendritic cells, Eur J Immunol, 27, 280, 10.1002/eji.1830270141 · DOI
  16. Giodini, 2008, Hsp90-mediated cytosolic refolding of exogenous proteins internalized by dendritic cells, Embo J, 27, 201, 10.1038/sj.emboj.7601941 · DOI
  17. Sanchez-Rico, 2017, Effects of fluorophore attachment on protein conformation and dynamics studied by spFRET and NMR spectroscopy, Chemistry, 23, 14267, 10.1002/chem.201702423 · DOI
  18. van Leeuwen, 2021, Bioorthogonal protein labelling enables the study of antigen processing of citrullinated and carbamylated auto-antigens, RSC Chem Biol, 2, 855, 10.1039/D1CB00009H · DOI
  19. Baranov, 2019, The phosphoinositide kinase PIKfyve promotes Cathepsin-S-mediated major histocompatibility complex class II antigen presentation, iScience, 11, 160, 10.1016/j.isci.2018.12.015 · DOI
  20. Castelvecchi, 2022, Chemists who invented revolutionary “click” reactions win Nobel, Nature, 610, 242, 10.1038/d41586-022-03087-8 · DOI
  21. Hos, 2018, Approaches to improve chemically defined synthetic peptide vaccines, Front Immunol, 9, 884, 10.3389/fimmu.2018.00884 · DOI
  22. Pawlak, 2016, The optimization of bioorthogonal epitope ligation within MHC-I complexes, ACS Chem Biol, 11, 3172, 10.1021/acschembio.6b00498 · DOI
  23. Sletten, 2009, Bioorthogonal chemistry: fishing for selectivity in a sea of functionality, Angew Chem Int Ed, 48, 6974, 10.1002/anie.200900942 · DOI · Paper page
  24. Scinto, 2021, Bioorthogonal chemistry, Nat Rev Methods Primers, 1, 30, 10.1038/s43586-021-00028-z · DOI
  25. Bird, 2021, Bioorthogonal chemistry and its applications, Bioconjug Chem, 32, 2457, 10.1021/acs.bioconjchem.1c00461 · DOI
  26. Boyce, 2011, Bringing chemistry to life, Nat Methods, 8, 638, 10.1038/nmeth.1657 · DOI
  27. Meldal, 2008, Cu-catalyzed azide-alkyne cycloaddition, Chem Rev, 108, 2793, 10.1021/cr0783479 · DOI
  28. Rostovtsev, 2002, A stepwise huisgen cycloaddition process: Copper(I)-catalyzed regioselective “ligation” of azides and terminal alkynes, Angew Chem Int Ed, 41, 2596, 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4 · DOI · Paper page
  29. Bakkum, 2018, Quantification of bioorthogonal stability in immune phagocytes using flow cytometry reveals rapid degradation of strained alkynes, ACS Chem Biol, 13, 1173, 10.1021/acschembio.8b00355 · DOI
  30. van Hest, 2000, Efficient incorporation of unsaturated methionine analogues into proteins in vivo, J Am Chem Soc, 122, 1282, 10.1021/ja992749j · DOI
  31. Bertheussen, 2022, Live-cell imaging of sterculic acid—a naturally occurring 1,2-cyclopropene fatty acid—by bioorthogonal reaction with turn-on tetrazine-fluorophore conjugates, Angew Chem Int Ed, 61, e202207640, 10.1002/anie.202207640 · DOI
  32. Croce, 2020, Chemoenzymatic preparation of functional click-labeled messenger RNA, Chembiochem, 21, 1641, 10.1002/cbic.201900718 · DOI
  33. Tsuchiya, 2024, Post-click labeling enables highly accurate single cell analyses of glucose uptake ex vivo and in vivo, Commun Biol, 7, 459, 10.1038/s42003-024-06164-y · DOI
  34. He, 2020, Metabolic labeling and imaging of cellular RNA via bioorthogonal cyclopropene-tetrazine ligation, CCS Chem, 2, 89, 10.31635/ccschem.020.201900083 · DOI
  35. Seul, 2024, Cyclopropenes as chemical reporters for dual bioorthogonal and orthogonal metabolic labeling of DNA, Angew Chem Int Ed, 63, e202403044, 10.1002/anie.202403044 · DOI
  36. Salter, 1985, Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids, Immunogenetics, 21, 235, 10.1007/BF00375376 · DOI
  37. Bernabeu, 1984, β2-Microglobulin from serum associates with MHC class I antigens on the surface of cultured cells, Nature, 308, 642, 10.1038/308642a0 · DOI
  38. Banu, 2014, Building and optimizing a virus-specific T cell receptor library for targeted immunotherapy in viral infections, Sci Rep, 4, 4166, 10.1038/srep04166 · DOI
  39. Dou, 2018, HBV-derived synthetic long peptide can boost CD4+ and CD8+ T-cell responses in chronic HBV patients ex vivo, J Infect Dis, 217, 827, 10.1093/infdis/jix614 · DOI
  40. Gehring, 2011, Engineering virus-specific T cells that target HBV infected hepatocytes and hepatocellular carcinoma cell lines, J Hepatol, 55, 103, 10.1016/j.jhep.2010.10.025 · DOI
  41. Willems, 2014, N-tetradecylcarbamyl lipopeptides as novel agonists for Toll-like receptor 2, J Med Chem, 57, 6873, 10.1021/jm500722p · DOI
  42. Zom, 2016, TLR2 ligand-synthetic long peptide conjugates effectively stimulate tumor-draining lumph node T cells of cervical cancer patients, Oncotarget, 7, 67087, 10.18632/oncotarget.11512 · DOI
  43. Bolte, 2006, A guided tour into subcellular colocalization analysis in light microscopy, J Microsc, 224, 213, 10.1111/j.1365-2818.2006.01706.x · DOI
  44. Madden, 1993, The antigenic identity of peptide-MHC complexes: a comparison of the coformations of five viral peptides presented by HLA-A2, Cell, 75, 693, 10.1016/0092-8674(93)90490-H · DOI
  45. Pettersen, 2004, UCSF Chimera—a visualization system for exploratory research and analysis, J Comput Chem, 25, 1605, 10.1002/jcc.20084 · DOI
  46. Cerundolo, 1990, Presentation of viral antigen controlled by a gene in the major histocompatibility complex, Nature, 345, 449, 10.1038/345449a0 · DOI
  47. Hosken, 1990, Defective presentation of endogenous antigen by a cell line expressing class I molecules, Science, 248, 367, 10.1126/science.2326647 · DOI
  48. Eisen, 2012, Promiscuous binding of extracellular peptides to cell surface class I MHC protein, Proc Natl Acad Sci U S A, 109, 4580, 10.1073/pnas.1201586109 · DOI
  49. Santambriogo, 1999, Abundant empty class II MHC molecules on the surface of immature dendritic cells, Proc Natl Acad Sci U S A, 96, 15050, 10.1073/pnas.96.26.15050 · DOI
  50. D. P, 1995, Effect of TAP on the generation and intracellular trafficking of peptide-receptive major histocompatibility complex class I molecules, Immunity, 2, 137, 10.1016/S1074-7613(95)80014-X · DOI
  51. Shieh, 2015, CalFluors: a universal motif for fluorogenic azide probes across the visible spectrum, J Am Chem Soc, 137, 7145, 10.1021/jacs.5b02383 · DOI
  52. Diken, 2011, Selective uptake of naked vaccine RNA by dendritic cells is driven by macropinocytosis and abrogated upon DC maturation, Gene Ther, 18, 702, 10.1038/gt.2011.17 · DOI
  53. Sarkar, 2005, Selective inhibition by rottlerin of macropinocytosis in monocyte-derived dendritic cells, Immunology, 116, 513, 10.1111/j.1365-2567.2005.02253.x · DOI
  54. Dou, 2020, Design of TLR2-ligand-synthetic long peptide conjugates for therapeutic vaccination of chronic HBV patients, Antiviral Res, 178, 104746, 10.1016/j.antiviral.2020.104746 · DOI
  55. Bertoletti, 1997, Molecular features of the hepatitis B virus nucleocapsid T-cell epitope 18-27: interaction with HLA and T-cell receptor, Hepatology, 26, 1027, 10.1002/hep.510260435 · DOI
  56. Bertoletti, 1994, Cytotoxic T lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope, J Exp Med, 180, 933, 10.1084/jem.180.3.933 · DOI
  57. Ljunggren, 1990, Empty MHC class I molecules come out in the cold, Nature, 346, 476, 10.1038/346476a0 · DOI
  58. Stuber, 1994, Identification of wild-type and mutant p53 peptides binding to HLA-A2 assessed by a peptide loading-deficient cell line assay and a novel major histocompatibility complex class I peptide binding assay, Eur J Immunol, 24, 765, 10.1002/eji.1830240341 · DOI
  59. Wei, 1992, HLA-A2 molecules in an antigen processing mutant cell contain signal sequence-derived peptides, Nature, 356, 443, 10.1038/356443a0 · DOI
  60. Gray, 2025, The evolving T cell receptor recognition code: the rules are more like guidelines, Immunol Rev, 329, e13439, 10.1111/imr.13439 · DOI
  61. Kefalakes, 2015, Adaptation of the hepatitis B virus core protein to CD8(+) T-cell selection pressure, Hepatology, 62, 47, 10.1002/hep.27771 · DOI
  62. Besanceney-Webler, 2011, Increasing the efficacy of bioorthogonal click reactions for bioconjugation: a comparative study, Angew Chem Int Ed, 50, 8051, 10.1002/anie.201101817 · DOI
  63. Chen, 2009, Identification of HLA-A11-restricted CTL epitopes derived from HPV type 18 using DNA immunization, Cancer Biol Ther, 8, 2025, 10.4161/cbt.8.21.9732 · DOI
  64. Kuzushima, 2001, Efficient identification of HLA-A*2402-restricted cytomegalovirus-specific CD8+ T-cell epitopes by a computer algorithm and an enzyme-linked immunospot assay, Blood, 98, 1872, 10.1182/blood.V98.6.1872 · DOI
  65. Rodenko, 2006, Generation of peptide-MHC class I complexes through UV-mediated ligand exchange, Nat Protoc, 1, 1120, 10.1038/nprot.2006.121 · DOI
  66. Toebes, 2006, Design and use of conditional MHC class I ligands, Nat Med, 12, 246, 10.1038/nm1360 · DOI
  67. Hamley, 2022, Peptides for vaccine development, ACS Appl Bio Mater, 5, 905, 10.1021/acsabm.1c01238 · DOI · Paper page
  68. El-Barbry, 2020, Extracellular release of antigen by dendritic cell regurgitation promotes B cell activation through NF-kappaB/cRel, J Immunol, 205, 608, 10.4049/jimmunol.1900394 · DOI
  69. Le Roux, 2012, Antigen stored in dendritic cells after macropinocytosis is released unprocessed from late endosomes to target B cells, Blood, 119, 95, 10.1182/blood-2011-02-336123 · DOI
  70. Lelek, 2021, Single-molecule localization microscopy, Nat Rev Methods Primers, 1, 39, 10.1038/s43586-021-00038-x · DOI
  71. Bertoni, 1997, Human histocompatibility leukocyte antigen-binding supermotifs predict broadly cross-reactive cytotoxic T lymphocyte responses in patients with acute hepatitis, J Clin Invest, 100, 503, 10.1172/JCI119559 · DOI
  72. Godkin, 2005, Molecular analysis of HLA class II associations with hepatitis B virus clearance and vaccine nonresponsiveness, Hepatology, 41, 1383, 10.1002/hep.20716 · DOI
  73. Shapiro, 2023, The impact of immunopeptidomics: from basic research to clinical implementation, Semin Immunol, 66, 101727, 10.1016/j.smim.2023.101727 · DOI
  74. Ligthart, 2023, A lysosome-targeted tetrazine for organelle-specific click-to-release chemistry in antigen presenting cells, J Am Chem Soc, 145, 12630, 10.1021/jacs.3c02139 · DOI
  75. Rosalia, 2013, Dendritic cells process synthetic long peptides better than whole protein, improving antigen presentation and T-cell activation, Eur J Immunol, 43, 2554, 10.1002/eji.201343324 · DOI

Metadata

Authors
Mostert, T. P., Kessler, A. L., Luijten, R. J., Doelman, W., Isendoorn, M. M. E., Filippov, D. V., van Kasteren, S. I., & Buschow, S. I.
Venue
The Journal of Immunology
Publisher
Oxford University Press (OUP)
Published
2025-11-20
Volume
215
Issue
3
ISSN
  • 0022-1767
  • 1550-6606
DOI
10.1093/jimmun/vkaf312
Cited by
0
References
1
Language
en
Licence
creativecommons.org/licenses/by/4.0/ (vor, 1 d)
Funders
European Research Council (865175)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Bioorthogonal click chemistry to visualize an immunogenic HLA-A2-restricted hepatitis B virus epitope in human monocyte-derived dendritic cells. https://app.cochat.ai/papers/10.1093/jimmun/vkaf312
The paper
Mostert, T. P., Kessler, A. L., Luijten, R. J., Doelman, W., Isendoorn, M. M. E., Filippov, D. V., van Kasteren, S. I., & Buschow, S. I. (2026). Bioorthogonal click chemistry to visualize an immunogenic HLA-A2-restricted hepatitis B virus epitope in human monocyte-derived dendritic cells. The Journal of Immunology. https://doi.org/10.1093/jimmun/vkaf312